Prospective study assesses FGF23 and bone minerals in renal transplant recipients, indicating significant changes post-operation.
Objectives: The objective of the study is to assess fibroblast growth factor-23 (FGF23) and its association with bone minerals in renal transplant recipients. Materials and Methods: A prospective longitudinal study comprising 32 end-stage renal disease cases awaiting renal transplant was followed up for three months post-transplant. Statistical analysis: Data were analyzed using appropriate tests such as the Freidman test, Pearson correlation with Statistical Package for the Social Sciences 20, and GraphPad Prism 7. P <0.05 was considered statistically significant. Results: A significant difference was noted in fibroblast growth factor 23 (FGF23) levels between pre and post-transplantation samples, with an increasing trend until 1 month, and a decreasing 1 by 3 months post-transplantation. Parathyroid hormone (PTH) levels reached normal ranges immediately post-transplant, and further decreased to lower normal ranges by three months. Vitamin D levels increased in the 1 st week and stabilized thereafter. Glomerular filtration rate (GFR) increased post-transplant immediately and stabilized in the following months. Calcium levels improved by 1 month post-transplant and stabilized thereafter. Phosphorus decreased in the immediate post-transplant period, and then a slight increase was noted. GFR has shown a negative correlation ( r = -0.24, P < 0.01) with FGF23 when pre and post-transplant samples were considered together. Phosphorus showed a positive correlation ( r = 0.3, P < 0.001) with FGF23. Pre-transplant ( r = 0.36, P < 0.044) and 3 months post-transplant ( r = 0.44, P = 0.025), FGF23 levels showed a positive correlation with phosphorus. FGF23 levels increase significantly post-transplantation within three months of stable graft function. An increase in phosphorus levels within the normal range was noted, with a significant positive correlation with FGF23. Conclusions: Greater information about aberrant FGF23 and its effects on bone minerals is necessary to understand whether efforts to restore it after transplant are desirable.
No takes yet. Share an insight, caveat, or question.
Japa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: